Needle exchanges can prevent more HIV outbreaks like one in Indiana

June 24, 2015

Congress needs to immediately lift the ban on federal funding for needle exchange programs to counter the threat of HIV outbreaks among injection drug users like the one that has seen an alarming number of new cases erupt in a single rural Indiana county.

So say Johns Hopkins Bloomberg School of Public Health Professor Chris Beyrer, MD, MPH, and Steffanie A. Strathdee, PhD, director of the Institute of Global Health at the University of California-San Diego, in a commentary published online June 24 in The New England Journal of Medicine.

"There are going to be more of these outbreaks and what's urgently needed is a public health response before things get even worse," says Beyrer, who is also president of the International AIDS Society. "Now is the time to implement needle and syringe exchange programs, wherever they are needed. We can't put politics above public health. We have a cheap tool to prevent this."

The story of Scott County, Ind., a rural region of the state near the Kentucky border, is one that public health officials had feared. In the past decade, the face of drug abuse has changed. No longer is it an exclusively urban, male, African-American problem. It is now mainly concentrated mainly in rural white communities and roughly equally among men and women.

Often, they start out abusing prescription drugs, sometimes by mouth but often by injection, which then can be a gateway to heroin. In 25 states, over-the-counter syringe purchase is illegal without a prescription. Across the country, in states where needle exchanges are legal, programs are prohibited from using federal funds due to a ban that was lifted, in 2009, and then reinstated by Congress in 2011. It's a recipe ripe for HIV and hepatitis C infections to be transmitted quickly through a community, the researchers say.

Southeast Indiana had previously recorded only about five new cases of HIV a year. By June 10 of this year, 169 people had been newly diagnosed and more than 80 percent were also infected with the hepatitis C virus.

Needle exchanges are illegal in Indiana.

The state's governor has made an exception to allow for needle exchanges in the affected county, but says he will only allow other counties to start programs once they show a need.

"Regrettably in the case of NEPs [needle exchange programs], other Indiana counties contemplating authorizing them must first demonstrate the existence of a public health emergency - a requirement that ensures that they can only respond to, rather than prevent, new outbreaks," they write.

Another troubling aspect, the authors note, is that to get clean needles, people must give their initials and date of birth, a registration process that could deter use. And the programs are only open until 6 p.m. most evenings.

Other ways to counter the epidemic, Beyrer says, are to screen more people for HIV and ask them about their drug use, including white women, a demographic that may have been overlooked in prior screening. Beyrer says poor screening efforts mean fewer people in treatment for HIV. Identifying those with HIV earlier can lead to earlier treatment and suppression of viral load, making those with HIV less infectious to others.

Greater use of opioid replacement therapies - that is, replacing those drugs with methadone and buprenorphine, which are less dangerous - could also aid the battle.

These types of actions have worked in the past, Beyrer says. An explosive HIV outbreak among injection drug users that hit Vancouver, British Columbia, was controlled by the expansion of needle exchange programs, providing opioid replacement therapy and providing highly active antiretroviral therapy (HAART) free of charge through Canada's universal health care system.

"Drug use is changing and before this gets any worse, we need to change our approach to fighting it," Beyrer says.
-end-
"Threading the Needle - How to Stop the HIV Outbreak in Rural Indiana" was written by Steffanie A. Strathdee and Chris Beyrer.

Johns Hopkins University Bloomberg School of Public Health

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.